Abeona Therapeutics ABEO Stock
Abeona Therapeutics Price Chart
Abeona Therapeutics ABEO Financial and Trading Overview
| Abeona Therapeutics stock price | 3.65 USD |
| Previous Close | 4.68 USD |
| Open | 4.74 USD |
| Bid | 4.56 USD x 1400 |
| Ask | 4.8 USD x 1200 |
| Day's Range | 4.59 - 4.77 USD |
| 52 Week Range | 2.19 - 5.4 USD |
| Volume | 103.49K USD |
| Avg. Volume | 147.51K USD |
| Market Cap | 116.93M USD |
| Beta (5Y Monthly) | 1.259 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.53 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.25 USD |
ABEO Valuation Measures
| Enterprise Value | 67.88M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.7602336 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 32.77185 |
| Price/Book (mrq) | 5.2914796 |
| Enterprise Value/Revenue | 19.024 |
| Enterprise Value/EBITDA | -1.527 |
Trading Information
Abeona Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.259 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 5.4 USD |
| 52 Week Low | 2.19 USD |
| 50-Day Moving Average | 4.29 USD |
| 200-Day Moving Average | 3.68 USD |
ABEO Share Statistics
| Avg. Volume (3 month) | 147.51K USD |
| Avg. Daily Volume (10-Days) | 187.19K USD |
| Shares Outstanding | 24.77M |
| Float | 16.42M |
| Short Ratio | 3.22 |
| % Held by Insiders | 5.61% |
| % Held by Institutions | 51.88% |
| Shares Short | 548.99K |
| Short % of Float | 2.44% |
| Short % of Shares Outstanding | 2.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1316.61% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -56.0060% |
| Return on Equity (ttm) | -238.80% |
Income Statement
| Revenue (ttm) | 3.57M USD |
| Revenue Per Share (ttm) | 0.2 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -28001000 USD |
| EBITDA | -44451000 USD |
| Net Income Avi to Common (ttm) | -44718000 USD |
| Diluted EPS (ttm) | -1.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 53.75M USD |
| Total Cash Per Share (mrq) | 2.17 USD |
| Total Debt (mrq) | 5.69M USD |
| Total Debt/Equity (mrq) | 25.83 USD |
| Current Ratio (mrq) | 6.807 |
| Book Value Per Share (mrq) | 0.892 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41766000 USD |
| Levered Free Cash Flow (ttm) | -22618000 USD |
Profile of Abeona Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 1330 Avenue of the Americas |
| ZIP | 10019 |
| Phone | 646 813 4701 |
| Website | https://www.abeonatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 57 |
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.
Q&A For Abeona Therapeutics Stock
What is a current ABEO stock price?
Abeona Therapeutics ABEO stock price today per share is 3.65 USD.
How to purchase Abeona Therapeutics stock?
You can buy ABEO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abeona Therapeutics?
The stock symbol or ticker of Abeona Therapeutics is ABEO.
Which industry does the Abeona Therapeutics company belong to?
The Abeona Therapeutics industry is Biotechnology.
How many shares does Abeona Therapeutics have in circulation?
The max supply of Abeona Therapeutics shares is 56.58M.
What is Abeona Therapeutics Price to Earnings Ratio (PE Ratio)?
Abeona Therapeutics PE Ratio is now.
What was Abeona Therapeutics earnings per share over the trailing 12 months (TTM)?
Abeona Therapeutics EPS is -2.53 USD over the trailing 12 months.
Which sector does the Abeona Therapeutics company belong to?
The Abeona Therapeutics sector is Healthcare.
Abeona Therapeutics ABEO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}